Insider Trades46 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Sell | BCAX | Claire Mazumdar | Chief Executive Officer | 20,000 | $15.88 | $1.5B | -26.40% | +121.56% | $317.6K | +0.00% | 10b5-1 | Buy Now |
| Aug 10, 2026 | Sell | BCAX | Ivan Hyep | Chief Financial Officer | 25,000 | $15.88 | $1.5B | -26.40% | +121.56% | $397.0K | +0.00% | 10b5-1 | Buy Now |
| Aug 10, 2026 | Sell | BCAX | Ryan Cohlhepp | President and COO | 37,500 | $15.88 | $1.5B | -26.40% | +121.56% | $595.6K | +0.00% | 10b5-1 | Buy Now |
| Jul 10, 2026 | Sell | BCAX | Claire Mazumdar | Chief Executive Officer | 20,000 | $16.10 | $1.5B | -26.40% | +121.56% | $322.1K | +0.00% | 10b5-1 | Buy Now |
| Jul 8, 2026 | Sell | BCAX | Ivan Hyep | Chief Financial Officer | 40,500 | $21.11 | $1.5B | -26.40% | +121.56% | $855.0K | -2.32% | 10b5-1 | Buy Now |
| Jul 8, 2026 | Sell | BCAX | Ryan Cohlhepp | President and COO | 47,500 | $19.04 | $1.5B | -26.40% | +121.56% | $904.2K | -0.98% | 10b5-1 | Buy Now |
| May 21, 2026 | Sell | BCAX | Ivan Hyep | Chief Financial Officer | 18,400 | $12.11 | $1.5B | -26.40% | +121.56% | $222.7K | +0.00% | 10b5-1 | Buy Now |
| May 18, 2026 | Sell | BCAX | Claire Mazumdar | Chief Executive Officer | 30,000 | $11.91 | $1.5B | -26.40% | +121.56% | $357.4K | +0.00% | 10b5-1 | Buy Now |
| May 15, 2026 | Sell | BCAX | Ryan Cohlhepp | President and COO | 20,500 | $13.85 | $1.5B | -26.40% | +121.56% | $284.0K | -0.64% | 10b5-1 | Buy Now |
| Apr 27, 2026 | Sell | BCAX | David Raben | Chief Medical Officer | 11,000 | $13.33 | $1.5B | -26.40% | +121.56% | $146.7K | +0.00% | 10b5-1 | Buy Now |
| Apr 21, 2026 | Sell | BCAX | Ivan Hyep | Chief Financial Officer | 18,400 | $13.40 | $1.5B | -26.40% | +121.56% | $246.5K | +0.00% | 10b5-1 | Buy Now |
| Apr 16, 2026 | Buy | BCAX | Claire Mazumdar | Chief Executive Officer | 52,760 | $9.75 | $1.5B | -26.40% | +121.56% | $514.4K | +0.85% | 10b5-1 | Buy Now |
| Apr 15, 2026 | Sell | BCAX | Ryan Cohlhepp | President and COO | 20,500 | $15.51 | $1.5B | -26.40% | +121.56% | $317.9K | -0.63% | 10b5-1 | Buy Now |
| Mar 25, 2026 | Sell | BCAX | David Raben | Chief Medical Officer | 11,000 | $11.37 | $1.5B | -26.40% | +121.56% | $125.1K | +0.00% | 10b5-1 | Buy Now |
| Mar 23, 2026 | Sell | BCAX | Ivan Hyep | Chief Financial Officer | 18,400 | $11.15 | $1.5B | -26.40% | +121.56% | $205.2K | +0.00% | 10b5-1 | Buy Now |
| Mar 18, 2026 | Sell | BCAX | Claire Mazumdar | Chief Executive Officer | 30,000 | $11.31 | $1.5B | -26.40% | +121.56% | $339.2K | +0.00% | 10b5-1 | Buy Now |
| Mar 16, 2026 | Sell | BCAX | Ryan Cohlhepp | President and COO | 20,500 | $13.46 | $1.5B | -26.40% | +121.56% | $276.0K | -0.61% | 10b5-1 | Buy Now |
| Mar 9, 2026 | Sell | BCAX | Claire Mazumdar | Chief Executive Officer | 73,532 | $11.48 | $1.5B | -26.40% | +121.56% | $844.0K | +0.00% | 10b5-1 | Buy Now |
| Mar 4, 2026 | Sell | BCAX | Claire Mazumdar | Chief Executive Officer | 16,468 | $11.27 | $1.5B | -26.40% | +121.56% | $185.5K | +0.00% | 10b5-1 | Buy Now |
| Mar 3, 2026 | Sell | BCAX | Ivan Hyep | Chief Financial Officer | 33,036 | $11.01 | $1.5B | -26.40% | +121.56% | $363.6K | +0.00% | 10b5-1 | Buy Now |
| Mar 3, 2026 | Sell | BCAX | Ryan Cohlhepp | President and COO | 30,284 | $12.04 | $1.5B | -26.40% | +121.56% | $364.8K | -0.59% | 10b5-1 | Buy Now |
| Mar 3, 2026 | Sell | BCAX | David Raben | Chief Medical Officer | 33,000 | $11.16 | $1.5B | -26.40% | +121.56% | $368.1K | +0.00% | 10b5-1 | Buy Now |
| Feb 25, 2026 | Sell | BCAX | Ryan Cohlhepp | President and COO | 6,739 | $11.47 | $1.5B | -26.40% | +121.56% | $77.3K | -0.07% | 10b5-1 | Buy Now |
| Jan 22, 2026 | Sell | BCAX | Ivan Hyep | Chief Financial Officer | 3,764 | $10.97 | $1.5B | -26.40% | +121.56% | $41.3K | +0.00% | 10b5-1 | Buy Now |
| Jan 22, 2026 | Sell | BCAX | Ryan Cohlhepp | President and COO | 3,828 | $18.10 | $1.5B | -26.40% | +121.56% | $69.3K | -1.79% | 10b5-1 | Buy Now |
| Jan 15, 2026 | Sell | BCAX | Ryan Cohlhepp | President and COO | 149 | $18.02 | $1.5B | -26.40% | +121.56% | $2.7K | -0.07% | 10b5-1 | Buy Now |
| Dec 26, 2025 | Buy | BCAX | David Raben | Chief Medical Officer | 19,789 | $3.79 | $1.5B | -26.40% | +121.56% | $75.0K | +14.71% | — | Buy Now |
| Dec 26, 2025 | Buy | BCAX | Ryan Cohlhepp | President and COO | 25,000 | $4.44 | $1.5B | -26.40% | +121.56% | $110.9K | +10.91% | — | Buy Now |
| Dec 22, 2025 | Sell | BCAX | Ivan Hyep | Chief Financial Officer | 18,400 | $11.05 | $1.5B | -26.40% | +121.56% | $203.4K | +0.00% | 10b5-1 | Buy Now |
| Dec 16, 2025 | Buy | BCAX | Claire Mazumdar | Chief Executive Officer | 29,500 | $5.45 | $1.5B | -26.40% | +121.56% | $160.9K | +3.37% | — | Buy Now |
| Dec 15, 2025 | Sell | BCAX | Ryan Cohlhepp | President and COO | 20,500 | $12.87 | $1.5B | -26.40% | +121.56% | $263.9K | -0.62% | 10b5-1 | Buy Now |
| Nov 24, 2025 | Sell | BCAX | David Raben | Chief Medical Officer | 22,000 | $11.22 | $1.5B | -26.40% | +121.56% | $246.8K | +0.00% | 10b5-1 | Buy Now |
| Nov 24, 2025 | Sell | BCAX | Claire Mazumdar | Chief Executive Officer | 82,326 | $11.33 | $1.5B | -26.40% | +121.56% | $932.4K | +0.00% | 10b5-1 | Buy Now |
| Nov 21, 2025 | Sell | BCAX | Ryan Cohlhepp | President and COO | 20,500 | $12.48 | $1.5B | -26.40% | +121.56% | $255.9K | -0.60% | 10b5-1 | Buy Now |
| Nov 21, 2025 | Sell | BCAX | Ivan Hyep | Chief Financial Officer | 36,800 | $11.16 | $1.5B | -26.40% | +121.56% | $410.8K | +0.00% | 10b5-1 | Buy Now |
| Oct 16, 2025 | Sell | BCAX | Claire Mazumdar | Chief Executive Officer | 48,206 | $11.31 | $1.5B | -26.40% | +121.56% | $545.1K | +0.00% | 10b5-1 | Buy Now |
| Oct 15, 2025 | Sell | BCAX | Ryan Cohlhepp | President and COO | 20,500 | $12.55 | $1.5B | -26.40% | +121.56% | $257.3K | -0.58% | 10b5-1 | Buy Now |
| Oct 13, 2025 | Sell | BCAX | Claire Mazumdar | Chief Executive Officer | 49,468 | $11.33 | $1.5B | -26.40% | +121.56% | $560.7K | +0.00% | 10b5-1 | Buy Now |
| Oct 9, 2025 | Sell | BCAX | Ivan Hyep | Chief Financial Officer | 12,830 | $11.01 | $1.5B | -26.40% | +121.56% | $141.2K | +0.00% | 10b5-1 | Buy Now |
| Oct 9, 2025 | Sell | BCAX | David Raben | Chief Medical Officer | 44,000 | $11.12 | $1.5B | -26.40% | +121.56% | $489.3K | +0.00% | 10b5-1 | Buy Now |
| Oct 6, 2025 | Sell | BCAX | Ivan Hyep | Chief Financial Officer | 60,770 | $11.00 | $1.5B | -26.40% | +121.56% | $668.4K | +0.00% | 10b5-1 | Buy Now |
| Oct 6, 2025 | Sell | BCAX | Ryan Cohlhepp | President and COO | 82,500 | $12.52 | $1.5B | -26.40% | +121.56% | $1.0M | -1.12% | 10b5-1 | Buy Now |
| Sep 29, 2025 | Sell | BCAX | Lara Meisner | Chief Legal Officer | 67,614 | $12.00 | $1.5B | -26.40% | +121.56% | $811.1K | +0.00% | 10b5-1 | Buy Now |
| Sep 15, 2025 | Sell | BCAX | Lara Meisner | Chief Legal Officer | 31,658 | $8.47 | $1.5B | -26.40% | +121.56% | $268.1K | +0.00% | 10b5-1 | Buy Now |
| Jun 16, 2025 | Sell | BCAX | Lara Meisner | Chief Legal Officer | 31,658 | $7.94 | $1.5B | -26.40% | +121.56% | $251.4K | +0.00% | 10b5-1 | Buy Now |
| Mar 14, 2025 | Sell | BCAX | Lara Meisner | Chief Legal Officer | 158,292 | $9.18 | $1.5B | -26.40% | +121.56% | $1.5M | +0.00% | 10b5-1 | Buy Now |